Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David P. Perry currently holds 2,416,634 shares of Better Therapeutics, Inc. (BTTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David P. Perry has been a net seller of BTTX stock. They have purchased $900.1K and sold $3.3M worth of shares.
David P. Perry's most recent insider trade was on Feb 9, 2024, when they sold 839,895 shares at $0.19 per share.
David P. Perry serves as Executive at Better Therapeutics, Inc. (BTTX). They have executed 18 insider transactions totaling $4.2M over their tenure at the company.
David P. Perry holds the position of Executive at Better Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
David P. Perry has shown a selling trading pattern, with $900.1K in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David P. Perry was on Mar 4, 2014, when they sold $1.0M worth of ANAC shares. This transaction involved 50,000 shares at $20.22 per share.
David P. Perry currently owns 2,416,634 shares of Better Therapeutics, Inc. (BTTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David P. Perry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David P. Perry has 18 Form 4 filings on record as an insider at Better Therapeutics, Inc..
Set alerts for David P. Perry and 40,000+ other insiders.